首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

市场调查报告书

商品编码

1795986

全球PCR检测市场

PCR Tests

出版日期: 2025年08月22日 | 出版商:

Global Industry Analysts, Inc. | 英文 479 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球 PCR 检测市场规模将达 325 亿美元

全球PCR检测市场规模预计在2024年达到238亿美元，预计2024年至2030年期间的复合年增长率为5.4%，到2030年将达到325亿美元。标准PCR检测是本报告分析的细分市场之一，预计其复合年增长率为7.1%，到分析期结束时规模将达到148亿美元。即时PCR检测细分市场在分析期间的复合年增长率预计为3.6%。

美国市场规模估计为 65 亿美元，中国市场预期复合年增长率为 8.8%

预计到2024年，美国的PCR检测市场规模将达到65亿美元。作为世界第二大经济体的中国，预计2030年市场规模将达到66亿美元，2024年至2030年的复合年增长率为8.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为2.5%和5.4%。在欧洲，预计德国的复合年增长率为3.5%。

全球 PCR 检测市场 - 主要趋势和驱动因素摘要

为什么 PCR 检测仍然是分子诊断的黄金标准？

聚合酵素链锁反应(PCR) 检测因其高特异性、高灵敏度和多功能性，能够检测频谱核酸，包括病原体、遗传疾病和肿瘤生物标记物，因此一直处于分子诊断的前沿。 PCR 最初作为基础研究工具引入，现已成为临床诊断、食品安全检测、法医学分析和环境监测的核心。在 COVID-19 疫情期间，PCR 的应用在全球范围内激增，其在常规诊断和精准医疗领域的应用也持续发展。

在感染疾病诊断中，PCR 仍然是确认活动性性行为感染的黄金标准，而即时定量 PCR (qPCR) 和多重 PCR 系统则具有快速检测能力，并能够同时检测多个目标。这些能力对于控制呼吸道感染疾病（例如流感、呼吸道合胞病毒、SARS-CoV-2）、性行为感染传染病以及登革热和兹卡病毒等热带疾病至关重要。 PCR 也透过早期检测抗药性菌株（例如抗甲氧西林金黄色葡萄球菌 (MRSA) 和艰难梭菌）在医院感染控制中发挥关键作用。

除感染疾病外，PCR技术在基因筛检和产前筛检中也发挥重要作用，可用于检测单核苷酸筛检(SNP)、基因融合和染色体异常。肿瘤诊断越来越依赖基于PCR的检测方法，以识别肿瘤中可操作的突变、指导标靶治疗并监测微小残留病灶。在非临床领域，PCR技术用于水质检测、农业病原体检测和食品污染筛检，突显了其跨产业效用和标准化程度。

哪些技术进步正在再形成PCR 检测平台？

PCR技术的演进源自于对更高通量、更快循环时间、更大多重检测能力以及更佳照护现场(POC) 适用性的需求。传统的聚合酵素连锁反应热迴圈仪正被整合式系统所取代或补充，这些系统在一个密封单元内完成样品製备、扩增和检测。这降低了污染风险并简化了工作流程，尤其是在资源有限或现场环境中。

数位PCR（dPCR）是过去十年最重要的进展之一。透过将PCR反应分解为数千个纳升级的反应，dPCR无需标准曲线即可实现核酸的绝对定量。该技术在肿瘤学领域日益普及，因为它在液态切片应用和病毒量监测中，能够更准确地检测低丰度标靶。基于微流体技术的PCR设备，包括实验室晶片平台，也正在实现小型化和超快速处理，这对于紧急诊断和行动医疗应用至关重要。

随着综合检测的兴起，多重PCR技术正在不断改进，能够在单次反应中处理更多标靶。这对于诊断具有重迭症状的呼吸道和胃肠道疾病尤其有用。整合AI的PCR平台正在涌现，它们可以解读复杂的扩增数据，提供可能的诊断建议，并将其输入集中式资料库，用于疫情监测和病患记录整合。这些智慧型系统有望重新定义诊断资料的收集、处理和利用方式。

哪些最终用途领域和全球地区正在推动 PCR 市场成长？

医院、诊断参考实验室、学术研究中心、生技公司和公共卫生机构是PCR检测技术的主要终端使用者。医院分子实验室致力于实现高通量PCR工作流程的自动化，以减少检测积压并支援快速的临床决策。参考实验室处理多个疾病领域的大量检测，通常使用多重和数位PCR平台来扩展其检测范围并支援合约研究。

研究实验室使用PCR检验基因编辑实验、分析基因表现并进行微生物定序。生物製药公司依靠基于PCR的检测方法进行临床试验、污染控制和药物基因组学筛选中的产品安全测试。监管机构和食品安全部门使用PCR来追踪全球供应链中的基因改造生物 (GMO)、毒素或禁用物质，确保符合公共卫生标准。

从地理上看，北美在应用方面处于领先地位，这得益于其完善的实验室基础设施、分子检测的保险报销以及美国生物技术公司的持续创新。欧洲紧随其后，得益于协调一致的公共卫生筛检计画和欧盟诊断设备製造商的支持。亚太地区正在经历快速成长，尤其是在中国、印度和东南亚，这些地区的感染疾病负担、公共卫生投资以及不断提升的分子检测能力正在推动需求成长。拉丁美洲和非洲虽然仍是新兴市场，但在全球卫生资金和疫情防控计画的推动下，PCR 的应用正在增加。

哪些因素推动了全球 PCR 检测市场的成长？

全球 PCR 检测市场的成长受到以下因素的推动：对早期和准确诊断的持续需求、感染疾病负担的增加、肿瘤学和基因检测应用的不断扩大、以及 PCR 自动化、小型化和多路復用的持续进步。随着医疗保健向精准医疗转变，临床和临床前环境中对基于核酸的测试的需求都在增加。

病毒爆发、抗生素抗药性和通用感染疾病等持续存在的威胁，正在刺激对能够快速、多重病原体检测的即时PCR平台的投资。各国政府为加强诊断能力倡议，加上世界卫生组织、美国疾病管制与预防中心和盖兹基金会的资助，正在使PCR检测的普及率更高，尤其是在医疗资源匮乏的地区。 PCR在分散式检查中的新兴应用，例如家用分子检测套件和即时诊断设备，正在将市场拓展到机构实验室之外。

此外，PCR在伴随诊断、移植监测、产前筛检和个人化治疗监测中的作用日益增强，确保了该市场的长期相关性。监管环境也日趋成熟，检测套组核准、紧急使用授权和品管标准的途径日益增加。随着分子生物学继续支撑现代医学，PCR技术仍然是一项必不可少、灵活且扩充性的工具，并有望持续成长。

部分

测试类型（标准、即时、数位、其他测试类型）、产品类型（仪器、试剂和耗材、软体和服务）、适应症（感染疾病、肿瘤学、遗传疾病、其他适应症）、最终用户（医院和诊所、製药和生物技术行业、诊断中心、其他最终用户）

受访公司范例

Abbott Laboratories
Agilent Technologies
Becton, Dickinson & Co.（BD）
BGI Genomics
Bio-Rad Laboratories
Cepheid（Danaher）
DiaSorin SpA
Eurofins Scientific
F. Hoffmann-La Roche Ltd
Fujirebio
GenMark Diagnostics
Hologic
Illumina Inc.
LabCorp
Luminex Corporation
Meridian Bioscience
Myriad Genetics
Oxford Nanopore Technologies
PerkinElmer
Qiagen NV

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

The global market for PCR Tests estimated at US$23.8 Billion in the year 2024, is expected to reach US$32.5 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Standard PCR Test, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$14.8 Billion by the end of the analysis period. Growth in the Real-Time PCR Test segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.5 Billion While China is Forecast to Grow at 8.8% CAGR

The PCR Tests market in the U.S. is estimated at US$6.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.6 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global PCR Tests Market - Key Trends & Drivers Summarized

Why Are PCR Tests Still the Gold Standard in Molecular Diagnostics?

Polymerase Chain Reaction (PCR) testing continues to stand at the forefront of molecular diagnostics due to its high specificity, sensitivity, and versatility in detecting nucleic acids across a broad spectrum of pathogens, genetic conditions, and oncology biomarkers. While initially introduced as a tool for basic research, PCR has become central to clinical diagnostics, food safety testing, forensic analysis, and environmental monitoring. Its application surged globally during the COVID-19 pandemic, and its relevance continues to evolve across routine diagnostics and precision medicine.

In infectious disease diagnostics, PCR remains the gold standard for confirming active infections, with real-time quantitative PCR (qPCR) and multiplex PCR systems offering rapid turnaround and the ability to detect multiple targets simultaneously. These capabilities are essential for managing respiratory infections (e.g., influenza, RSV, SARS-CoV-2), sexually transmitted infections, and tropical diseases such as dengue and Zika. PCR also plays a crucial role in hospital-acquired infection control by enabling early detection of drug-resistant strains like MRSA or C. difficile.

Outside infectious disease, PCR is integral in genetic and prenatal screening, detecting single-nucleotide polymorphisms (SNPs), gene fusions, and chromosomal abnormalities. Oncology diagnostics increasingly rely on PCR-based assays to identify actionable mutations in tumors, guide targeted therapies, and monitor minimal residual disease. In non-clinical domains, PCR is used in water testing, agricultural pathogen detection, and food contamination screening, emphasizing its cross-industry utility and standardization.

What Technological Advancements Are Reshaping PCR Testing Platforms?

The evolution of PCR technologies has been shaped by a need for higher throughput, faster cycling times, greater multiplexing capability, and improved point-of-care (POC) applicability. Traditional thermal cyclers are being replaced or supplemented by integrated systems combining sample preparation, amplification, and detection in a single closed unit. This reduces contamination risks and simplifies workflow, particularly in resource-limited or field-based settings.

Digital PCR (dPCR) represents one of the most significant advances in the last decade. By partitioning the PCR reaction into thousands of nanoliter-scale reactions, dPCR enables absolute quantification of nucleic acids without the need for standard curves. This technology is gaining traction in oncology for liquid biopsy applications and in viral load monitoring, offering higher precision in low-abundance targets. Microfluidic-based PCR devices, including lab-on-a-chip platforms, are also enabling miniaturization and ultra-fast processing, crucial for emergency diagnostics and mobile health applications.

Multiplex PCR technologies are being refined to handle increasing numbers of targets in a single reaction, driven by the rise in syndromic panel testing. This is especially valuable for diagnosing respiratory or gastrointestinal diseases where symptoms overlap. AI-integrated PCR platforms are emerging that can interpret complex amplification data, suggest probable diagnoses, and feed into centralized databases for outbreak surveillance or patient record integration. These smart systems are expected to redefine how diagnostic data is collected, processed, and utilized.

Which End-Use Segments and Global Regions Are Fueling PCR Market Expansion?

Hospitals, diagnostic reference laboratories, academic research centers, biotechnology firms, and public health agencies are the core end-users of PCR test technologies. Hospital-based molecular labs are focusing on automating high-throughput PCR workflows to reduce test backlogs and support rapid clinical decision-making. Reference labs process large test volumes across multiple disease domains, often using multiplex and dPCR platforms to expand test menus and support contract research.

Research institutions use PCR to validate gene editing experiments, profile gene expression, and perform microbial sequencing. Biopharma firms depend on PCR-based assays for product safety testing, contamination control, and pharmacogenomic screening in clinical trials. Regulatory bodies and food safety authorities utilize PCR to track genetically modified organisms (GMOs), toxins, or banned substances across global supply chains, ensuring compliance with public health standards.

Geographically, North America leads in adoption due to well-established lab infrastructure, insurance reimbursement for molecular tests, and ongoing innovation from U.S.-based biotech companies. Europe is a close second, supported by coordinated public health screening programs and EU-based diagnostic manufacturers. Asia-Pacific is witnessing rapid growth, especially in China, India, and Southeast Asia, where infectious disease burden, public health investment, and rising molecular lab capacity drive demand. Latin America and Africa, while still emerging markets, are experiencing increased PCR deployment through global health funding initiatives and pandemic preparedness programs.

What Factors Are Propelling Growth in the Global PCR Tests Market?

The growth in the global PCR tests market is driven by the persistent need for early and accurate diagnosis, increasing infectious disease burden, expanding applications in oncology and genetic testing, and continual advancements in PCR automation, miniaturization, and multiplexing. As healthcare shifts toward precision medicine, the demand for nucleic acid-based testing is rising across both clinical and non-clinical settings.

Ongoing threats of viral outbreaks, antimicrobial resistance, and zoonotic diseases are fueling investments in real-time PCR platforms capable of rapid, multiplexed pathogen detection. Government initiatives to strengthen diagnostic capacity, along with funding from WHO, CDC, and Gates Foundation, are enabling broader PCR test availability, particularly in underserved regions. Emerging uses of PCR in decentralized testing, such as at-home molecular kits and POC devices, are expanding the market beyond institutional labs.

Moreover, PCR’s expanding role in companion diagnostics, transplant monitoring, prenatal screening, and personalized therapy monitoring ensures long-term market relevance. The regulatory landscape is also maturing, with increased pathways for test kit approvals, emergency use authorizations, and quality control standards. With molecular biology continuing to underpin modern medicine, PCR technologies remain indispensable, flexible, and highly scalable tools poised for enduring growth.

SCOPE OF STUDY:

The report analyzes the PCR Tests market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Standard PCR Test, Real-Time PCR Test, Digital PCR Test, Other Test Types); Product Type (Instruments, Reagents & Consumables, Software & Services); Indication (Infectious Diseases, Oncology, Genetic Disorders, Other Indications); End-Use (Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

Abbott Laboratories
Agilent Technologies
Becton, Dickinson & Co. (BD)
BGI Genomics
Bio-Rad Laboratories
Cepheid (Danaher)
DiaSorin S.p.A.
Eurofins Scientific
F. Hoffmann-La Roche Ltd
Fujirebio
GenMark Diagnostics
Hologic
Illumina Inc.
LabCorp
Luminex Corporation
Meridian Bioscience
Myriad Genetics
Oxford Nanopore Technologies
PerkinElmer
Qiagen N.V.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Tariff Impact on Global Supply Chain Patterns
- PCR Tests - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Post-Pandemic Focus on Molecular Diagnostics Throws the Spotlight on PCR Test Capabilities
- Expansion of Decentralized and Point-of-Care Testing Drives Demand for Portable PCR Platforms
- Emergence of Multiplex Testing Technologies Strengthens Business Case for PCR-Based Panels
- Rising Infectious Disease Surveillance Initiatives Propel Routine Use of PCR Tests
- Genetic Testing and Precision Medicine Trends Accelerate Use of PCR in Clinical Diagnostics
- Technological Advancements in Real-Time PCR Enhance Speed, Accuracy, and Sensitivity
- Demand for Rapid Turnaround in Hospital Settings Fuels Growth in High-Throughput PCR Instruments
- Adoption of PCR in Food Safety and Agricultural Testing Expands Industrial Application Base
- Regulatory Approvals for At-Home PCR Kits Create Direct-to-Consumer Market Opportunities
- Integration with LIMS and Digital Health Platforms Enables Remote PCR Test Management
- Increasing Focus on Antimicrobial Resistance Drives Use of PCR in Pathogen Identification
- Research and Academic Sector Investment Supports Broad Adoption of qPCR and Digital PCR
- Rising Prevalence of Hereditary and Rare Diseases Spurs Growth in Gene Mutation Detection Tests
- Collaboration with Diagnostic Labs Enhances Product Accessibility and Test Customization
- Growth in Companion Diagnostics and Oncology Drives PCR Adoption in Targeted Therapy Pathways
- Development of Open-Access PCR Platforms Supports Flexible Assay Development in Labs
- Demand for Saliva- and Swab-Based Non-Invasive Tests Expands Consumer PCR Testing Preference
- Supply Chain Stability and Reagent Availability Drive Strategic Sourcing and Vendor Lock-In
- AI and Cloud-Based Data Analytics Tools Strengthen Post-PCR Data Interpretation and Automation
- Expansion of Veterinary Diagnostics Propels Use of PCR in Livestock and Zoonotic Surveillance
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World PCR Tests Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for PCR Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for PCR Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 4: World 16-Year Perspective for PCR Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Standard PCR Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Standard PCR Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 7: World 16-Year Perspective for Standard PCR Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Real-Time PCR Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Real-Time PCR Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 10: World 16-Year Perspective for Real-Time PCR Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Digital PCR Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Digital PCR Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 13: World 16-Year Perspective for Digital PCR Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 16: World 16-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Genetic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Genetic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 19: World 16-Year Perspective for Genetic Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 22: World 16-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 25: World 16-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 28: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 31: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Pharma & Biotech Industries End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 33: World Historic Review for Pharma & Biotech Industries End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 34: World 16-Year Perspective for Pharma & Biotech Industries End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 35: World Recent Past, Current & Future Analysis for Diagnostics Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 36: World Historic Review for Diagnostics Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 37: World 16-Year Perspective for Diagnostics Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 40: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 41: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 42: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 43: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 44: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 45: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 46: World 16-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 47: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 48: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 49: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 50: USA Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 51: USA Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 52: USA 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 53: USA Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 54: USA Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 55: USA 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 56: USA Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 57: USA Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 58: USA 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 59: USA Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 60: USA Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 61: USA 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
CANADA
- TABLE 62: Canada Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 63: Canada Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 64: Canada 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 65: Canada Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 66: Canada Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 67: Canada 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 68: Canada Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 69: Canada Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 70: Canada 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 71: Canada Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 72: Canada Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 73: Canada 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
JAPAN
- PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 74: Japan Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 75: Japan Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 76: Japan 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 77: Japan Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 78: Japan Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 79: Japan 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 80: Japan Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 81: Japan Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 82: Japan 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 83: Japan Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 84: Japan Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 85: Japan 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
CHINA
- PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 86: China Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 87: China Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 88: China 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 89: China Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 90: China Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 91: China 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 92: China Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 93: China Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 94: China 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 95: China Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 96: China Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 97: China 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
EUROPE
- PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 98: Europe Recent Past, Current & Future Analysis for PCR Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 99: Europe Historic Review for PCR Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 100: Europe 16-Year Perspective for PCR Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
- TABLE 101: Europe Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 102: Europe Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 103: Europe 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 104: Europe Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 105: Europe Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 106: Europe 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 107: Europe Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 108: Europe Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 109: Europe 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 110: Europe Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 111: Europe Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 112: Europe 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
FRANCE
- PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 113: France Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 114: France Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 115: France 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 116: France Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 117: France Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 118: France 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 119: France Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 120: France Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 121: France 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 122: France Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 123: France Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 124: France 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
GERMANY
- PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 125: Germany Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 126: Germany Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 127: Germany 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 128: Germany Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 129: Germany Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 130: Germany 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 131: Germany Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 132: Germany Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 133: Germany 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 134: Germany Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 135: Germany Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 136: Germany 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
ITALY
- TABLE 137: Italy Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 138: Italy Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 139: Italy 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 140: Italy Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 141: Italy Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 142: Italy 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 143: Italy Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 144: Italy Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 145: Italy 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 146: Italy Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 147: Italy Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 148: Italy 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
UNITED KINGDOM
- PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 149: UK Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 150: UK Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 151: UK 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 152: UK Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 153: UK Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 154: UK 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 155: UK Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 156: UK Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 157: UK 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 158: UK Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 159: UK Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 160: UK 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
SPAIN
- TABLE 161: Spain Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 162: Spain Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 163: Spain 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 164: Spain Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 165: Spain Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 166: Spain 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 167: Spain Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 168: Spain Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 169: Spain 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 170: Spain Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 171: Spain Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 172: Spain 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
RUSSIA
- TABLE 173: Russia Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 174: Russia Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 175: Russia 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 176: Russia Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 177: Russia Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 178: Russia 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 179: Russia Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 180: Russia Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 181: Russia 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 182: Russia Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 183: Russia Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 184: Russia 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
REST OF EUROPE
- TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 186: Rest of Europe Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 187: Rest of Europe 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 189: Rest of Europe Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 190: Rest of Europe 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 192: Rest of Europe Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 193: Rest of Europe 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 195: Rest of Europe Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 196: Rest of Europe 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
ASIA-PACIFIC
- PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for PCR Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 198: Asia-Pacific Historic Review for PCR Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 199: Asia-Pacific 16-Year Perspective for PCR Tests by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
- TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 201: Asia-Pacific Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 202: Asia-Pacific 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 204: Asia-Pacific Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 205: Asia-Pacific 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 207: Asia-Pacific Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 208: Asia-Pacific 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 210: Asia-Pacific Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 211: Asia-Pacific 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
AUSTRALIA
- PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 212: Australia Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 213: Australia Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 214: Australia 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 215: Australia Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 216: Australia Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 217: Australia 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 218: Australia Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 219: Australia Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 220: Australia 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 221: Australia Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 222: Australia Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 223: Australia 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
INDIA
- PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 224: India Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 225: India Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 226: India 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 227: India Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 228: India Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 229: India 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 230: India Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 231: India Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 232: India 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 233: India Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 234: India Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 235: India 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
SOUTH KOREA
- TABLE 236: South Korea Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 237: South Korea Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 238: South Korea 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 239: South Korea Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 240: South Korea Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 241: South Korea 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 242: South Korea Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 243: South Korea Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 244: South Korea 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 245: South Korea Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 246: South Korea Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 247: South Korea 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
REST OF ASIA-PACIFIC
- TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 249: Rest of Asia-Pacific Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 250: Rest of Asia-Pacific 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 252: Rest of Asia-Pacific Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 253: Rest of Asia-Pacific 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 255: Rest of Asia-Pacific Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 256: Rest of Asia-Pacific 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 258: Rest of Asia-Pacific Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 259: Rest of Asia-Pacific 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
LATIN AMERICA
- PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 260: Latin America Recent Past, Current & Future Analysis for PCR Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 261: Latin America Historic Review for PCR Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 262: Latin America 16-Year Perspective for PCR Tests by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
- TABLE 263: Latin America Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 264: Latin America Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 265: Latin America 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 266: Latin America Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 267: Latin America Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 268: Latin America 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 269: Latin America Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 270: Latin America Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 271: Latin America 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 272: Latin America Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 273: Latin America Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 274: Latin America 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
ARGENTINA
- TABLE 275: Argentina Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 276: Argentina Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 277: Argentina 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 278: Argentina Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 279: Argentina Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 280: Argentina 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 281: Argentina Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 282: Argentina Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 283: Argentina 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 284: Argentina Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 285: Argentina Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 286: Argentina 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
BRAZIL
- TABLE 287: Brazil Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 288: Brazil Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 289: Brazil 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 290: Brazil Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 291: Brazil Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 292: Brazil 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 293: Brazil Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 294: Brazil Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 295: Brazil 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 296: Brazil Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 297: Brazil Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 298: Brazil 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
MEXICO
- TABLE 299: Mexico Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 300: Mexico Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 301: Mexico 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 302: Mexico Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 303: Mexico Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 304: Mexico 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 305: Mexico Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 306: Mexico Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 307: Mexico 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 308: Mexico Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 309: Mexico Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 310: Mexico 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
REST OF LATIN AMERICA
- TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 312: Rest of Latin America Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 313: Rest of Latin America 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 315: Rest of Latin America Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 316: Rest of Latin America 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 318: Rest of Latin America Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 319: Rest of Latin America 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 321: Rest of Latin America Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 322: Rest of Latin America 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
MIDDLE EAST
- PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 323: Middle East Recent Past, Current & Future Analysis for PCR Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 324: Middle East Historic Review for PCR Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 325: Middle East 16-Year Perspective for PCR Tests by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
- TABLE 326: Middle East Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 327: Middle East Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 328: Middle East 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 329: Middle East Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 330: Middle East Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 331: Middle East 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 332: Middle East Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 333: Middle East Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 334: Middle East 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 335: Middle East Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 336: Middle East Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 337: Middle East 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
IRAN
- TABLE 338: Iran Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 339: Iran Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 340: Iran 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 341: Iran Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 342: Iran Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 343: Iran 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 344: Iran Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 345: Iran Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 346: Iran 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 347: Iran Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 348: Iran Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 349: Iran 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
ISRAEL
- TABLE 350: Israel Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 351: Israel Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 352: Israel 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 353: Israel Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 354: Israel Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 355: Israel 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 356: Israel Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 357: Israel Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 358: Israel 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 359: Israel Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 360: Israel Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 361: Israel 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
SAUDI ARABIA
- TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 363: Saudi Arabia Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 364: Saudi Arabia 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 366: Saudi Arabia Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 367: Saudi Arabia 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 369: Saudi Arabia Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 370: Saudi Arabia 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 372: Saudi Arabia Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 373: Saudi Arabia 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
UNITED ARAB EMIRATES
- TABLE 374: UAE Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 375: UAE Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 376: UAE 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 377: UAE Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 378: UAE Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 379: UAE 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 380: UAE Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 381: UAE Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 382: UAE 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 383: UAE Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 384: UAE Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 385: UAE 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
REST OF MIDDLE EAST
- TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 387: Rest of Middle East Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 388: Rest of Middle East 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 390: Rest of Middle East Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 391: Rest of Middle East 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 393: Rest of Middle East Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 394: Rest of Middle East 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 396: Rest of Middle East Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 397: Rest of Middle East 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030
AFRICA
- PCR Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 398: Africa Recent Past, Current & Future Analysis for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 399: Africa Historic Review for PCR Tests by Test Type - Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 400: Africa 16-Year Perspective for PCR Tests by Test Type - Percentage Breakdown of Value Sales for Standard PCR Test, Real-Time PCR Test, Digital PCR Test and Other Test Types for the Years 2014, 2025 & 2030
- TABLE 401: Africa Recent Past, Current & Future Analysis for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 402: Africa Historic Review for PCR Tests by Indication - Genetic Disorders, Other Indications, Infectious Diseases and Oncology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 403: Africa 16-Year Perspective for PCR Tests by Indication - Percentage Breakdown of Value Sales for Genetic Disorders, Other Indications, Infectious Diseases and Oncology for the Years 2014, 2025 & 2030
- TABLE 404: Africa Recent Past, Current & Future Analysis for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 405: Africa Historic Review for PCR Tests by End-Use - Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 406: Africa 16-Year Perspective for PCR Tests by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Pharma & Biotech Industries End-Use, Diagnostics Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
- TABLE 407: Africa Recent Past, Current & Future Analysis for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 408: Africa Historic Review for PCR Tests by Product Type - Instruments, Reagents & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 409: Africa 16-Year Perspective for PCR Tests by Product Type - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2014, 2025 & 2030

IV. COMPETITION

02-2729-4219

+886-2-2729-4219

License/价格

全球PCR检测市场

PCR Tests

受访公司范例

目录

第一章调查方法

第二章执行摘要

第三章市场分析

第四章竞赛

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

全球PCR检测市场

PCR Tests

受访公司范例

目录

第一章调查方法

第二章执行摘要

第三章市场分析

第四章 竞赛

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

第四章竞赛